Switzerland· 55674002
Caverject DC 20, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze
A alprostadil product, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Alprostadil is registered in 11 of 19 countries.
Countries holding a registration under ATC G04BE01 (alprostadil), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Alprostadil · ATC G04BE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
Price per daily dose
What a daily dose of alprostadil costs, country by country.
Normalised to the WHO defined daily dose (20 mcg), so markets compare like for like.
- Switzerland: $41.30 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Alprostadil · price per daily dose (20 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$41.30
The record
At a glance
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- G04BE01
- ATC class
- Alprostadil
- Defined daily dose
- 20 mcg, P
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for alprostadil.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alprostadil · interactions on record
85 records
- 22 moderate
- 62 info
Most severe, free to view
- LorcaserinA08AA11moderate
- DapagliflozinA10BK01moderate
- CanagliflozinA10BK02moderate
- EmpagliflozinA10BK03moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04BE01
Alprostadil, as other registers publish it.
- NorwayAlprostadil2care4 ApS
- NorwayAlprostadil2care4 ApS
- DenmarkAlprostadil "2care4"2care4 ApS
- NetherlandsAlprostadil Recordati 2 mg/g CrèmeRecordati Ireland Ltd. (Co. Cork)
- NetherlandsAlprostadil Recordati 3 mg/g CrèmeRecordati Ireland Ltd. (Co. Cork)
- NetherlandsAlprostadil Simple Pharma 300 microgram, crèmeThe Simple Pharma Company Limited
- SwitzerlandCaverject
- NorwayCaverjectPfizer Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b893103a-304c-4a4a-9668-8efe3ab7997e GET /v1/drugs/b893103a-304c-4a4a-9668-8efe3ab7997e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about alprostadil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.